[Imipenem/Cilastatin/Relebactam (bacterial infections, several therapeutic indications, < 18 years)]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018015830
German
Original Title: Imipenem/Cilastatin/Relebactam (bakterielle Infektionen, mehrere Anwendungsgebiete, < 18 Jahre)
Details
Project Status: Completed
URL for project: https://www.iqwig.de/projekte/g26-06.html
Year Published: 2026
URL for published report: https://www.iqwig.de/download/g26-06_imipenem-cilastatin-relebactam_bewertung-35a-absatz-1c-sgb-v_v1-0.pdf
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
DOI: https://doi.org/10.60584/G26-06
MeSH Terms
  • Anti-Bacterial Agents
  • beta-Lactamase Inhibitors
  • Cilastatin
  • Cilastatin, Imipenem Drug Combination
  • Imipenem
  • Gram-Negative Bacterial Infections
  • Bacteremia
  • Healthcare-Associated Pneumonia
Keywords
  • Imipenem
  • Cilastatin
  • Relebactam
  • Healthcare-Associated Pneumonia
  • Bacteremia
  • GramNegative Bacterial Infections
  • Child
  • Adolescent
  • Health Care Costs
  • Epidemiology
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.